Cargando…

Viruses

Viral infections are an important and often unrecognized component of disease in immunocompromised patients. The diagnosis and management of viral infections have expanded largely because of new quantitative molecular diagnostic assays. Well-recognized pathogens such as herpes simplex virus (HSV), c...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Stanley I., Fishman, Jay A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114983/
http://dx.doi.org/10.1007/978-1-59745-415-5_2
_version_ 1783514001339056128
author Martin, Stanley I.
Fishman, Jay A.
author_facet Martin, Stanley I.
Fishman, Jay A.
author_sort Martin, Stanley I.
collection PubMed
description Viral infections are an important and often unrecognized component of disease in immunocompromised patients. The diagnosis and management of viral infections have expanded largely because of new quantitative molecular diagnostic assays. Well-recognized pathogens such as herpes simplex virus (HSV), cytomegalovirus (CMV), and respiratory viruses have been joined by newly recognized pathogens such as BK virus, human herpesvirus-6 (HHV-6), and human metapneumovirus in this highly susceptible patient population. The role of Epstein-Barr virus (EBV) and Human herpesvirus-8 (HHV-8) in lymphoproliferative diseases also continue to be clarified. As a result, the management of viral infections in patients with hematologic malignancies continues to be a growing challenge for the clinician.
format Online
Article
Text
id pubmed-7114983
institution National Center for Biotechnology Information
language English
publishDate 2009
record_format MEDLINE/PubMed
spelling pubmed-71149832020-04-02 Viruses Martin, Stanley I. Fishman, Jay A. Managing Infections in Patients With Hematological Malignancies Article Viral infections are an important and often unrecognized component of disease in immunocompromised patients. The diagnosis and management of viral infections have expanded largely because of new quantitative molecular diagnostic assays. Well-recognized pathogens such as herpes simplex virus (HSV), cytomegalovirus (CMV), and respiratory viruses have been joined by newly recognized pathogens such as BK virus, human herpesvirus-6 (HHV-6), and human metapneumovirus in this highly susceptible patient population. The role of Epstein-Barr virus (EBV) and Human herpesvirus-8 (HHV-8) in lymphoproliferative diseases also continue to be clarified. As a result, the management of viral infections in patients with hematologic malignancies continues to be a growing challenge for the clinician. 2009-08-31 /pmc/articles/PMC7114983/ http://dx.doi.org/10.1007/978-1-59745-415-5_2 Text en © Humana Press 2009 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Martin, Stanley I.
Fishman, Jay A.
Viruses
title Viruses
title_full Viruses
title_fullStr Viruses
title_full_unstemmed Viruses
title_short Viruses
title_sort viruses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114983/
http://dx.doi.org/10.1007/978-1-59745-415-5_2
work_keys_str_mv AT martinstanleyi viruses
AT fishmanjaya viruses